A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bosutinib Impurity 3 | CAS 17722-32-6 - Request Quote

Picture of Bosutinib Impurity 3

Bosutinib Impurity 3

SZ CAT No:SZ-B063012
CAS No
17722-32-6
Mol.F.
C9H6Cl2N2O
Mol.Wt.
229.1
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Bosutinib Impurity 3 is chemically 2-Cyano-N-(2,4-dichlorophenyl)acetamide. Bosutinib Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Bosutinib Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bosutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 17722-32-6

Purchase 17722-32-6

Order 17722-32-6

Enquire 17722-32-6

price of 17722-32-6

17722-32-6 Supplier

17722-32-6 Manufacturer

17722-32-6 Exporter

buy high quality Bosutinib Impurity 3

Purchase Bosutinib Impurity 3

Bosutinib Impurity 3 suppliers

Bosutinib Impurity 3 manufacturers

Bosutinib Impurity 3 price

Order Bosutinib Impurity 3

Enquire Bosutinib Impurity 3

Bosutinib Impurity 3 cost

Bosutinib Impurity 3 Supplier

Bosutinib Impurity 3 Distributor

Bosutinib Impurity 3 for Method Validation

Bosutinib Reference Standard

Bosutinib Impurity 3 for ANDA Filing

Bosutinib Impurity 3 for Forced Degradation Studies

Bosutinib Impurity 3 Identification Standards

Bosutinib Impurity 3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,